Furthermore, our RNA‐sequencing data demonstrated that 3 of the genes (SCN5A, L1CAM, BMP2) affected with the anti‐ELTD1 treatment that were directly associated with gliomas influenced and interacted with Notch signalling. This evidence concerns the gene SCN5A and central nervous system cancer.